Artiva Biotherapeutics, Inc.
ARTV
$3.60
$0.020.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.53M | -21.25M | -20.31M | -16.10M | -17.47M |
| Total Depreciation and Amortization | 662.00K | 641.00K | 628.00K | 614.00K | 627.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.27M | 1.04M | 1.33M | 1.14M | 2.23M |
| Change in Net Operating Assets | 391.00K | -3.41M | -1.49M | -311.00K | 3.01M |
| Cash from Operations | -19.20M | -22.98M | -19.84M | -14.65M | -11.61M |
| Capital Expenditure | -600.00K | -1.06M | -511.00K | -64.00K | -96.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.88M | 22.18M | 10.48M | -902.00K | -130.53M |
| Cash from Investing | 16.28M | 21.12M | 9.97M | -966.00K | -130.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -32.00K | -33.00K | -33.00K | -33.00K | -38.00K |
| Issuance of Common Stock | 0.00 | 0.00 | 138.00K | 23.00K | 166.51M |
| Repurchase of Common Stock | -104.00K | -39.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.00K | 0.00 | 134.00K | -20.00K | -2.60M |
| Cash from Financing | -37.00K | -72.00K | 239.00K | -30.00K | 163.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.96M | -1.93M | -9.63M | -15.65M | 21.63M |